Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumJason W.‐L. Eng, Jan Kitajewski, Yu Kato et al.|Cancer Research Communications|2024Cited by 7
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillanceHideto Kameda, Yoshiya Tanaka, Sadatomo Tasaka et al.|Modern Rheumatology|2023Cited by 4
Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a postmarketing surveillance studyHideto Kameda, Yoshiya Tanaka, Sadatomo Tasaka et al.|Modern Rheumatology|2024Cited by 4
Figure 1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumJason W.‐L. Eng, Jan Kitajewski, Yu Kato et al.|Unknown|2024Cited by 0
Figure 3 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumJason W.‐L. Eng, Jan Kitajewski, Yasuhiro Funahashi et al.|Unknown|2024Cited by 0